NO792633L - Fremgangsmaate og sammensetning for noeytralisering eller oedeleggelse av virus - Google Patents
Fremgangsmaate og sammensetning for noeytralisering eller oedeleggelse av virusInfo
- Publication number
- NO792633L NO792633L NO792633A NO792633A NO792633L NO 792633 L NO792633 L NO 792633L NO 792633 A NO792633 A NO 792633A NO 792633 A NO792633 A NO 792633A NO 792633 L NO792633 L NO 792633L
- Authority
- NO
- Norway
- Prior art keywords
- virus
- glutaric acid
- virucidal
- viruses
- living
- Prior art date
Links
- 241000700605 Viruses Species 0.000 title claims description 50
- 239000000203 mixture Substances 0.000 title claims description 22
- 238000000034 method Methods 0.000 title description 3
- 230000006378 damage Effects 0.000 title 1
- 238000006386 neutralization reaction Methods 0.000 title 1
- RTBFRGCFXZNCOE-UHFFFAOYSA-N 1-methylsulfonylpiperidin-4-one Chemical compound CS(=O)(=O)N1CCC(=O)CC1 RTBFRGCFXZNCOE-UHFFFAOYSA-N 0.000 claims description 42
- JFCQEDHGNNZCLN-UHFFFAOYSA-N anhydrous glutaric acid Natural products OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 claims description 42
- 230000003253 viricidal effect Effects 0.000 claims description 22
- 241000709661 Enterovirus Species 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 239000000645 desinfectant Substances 0.000 claims description 7
- 241000712461 unidentified influenza virus Species 0.000 claims description 4
- 241000725643 Respiratory syncytial virus Species 0.000 claims description 3
- 239000004094 surface-active agent Substances 0.000 claims description 3
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 2
- 208000002606 Paramyxoviridae Infections Diseases 0.000 claims description 2
- 241000700584 Simplexvirus Species 0.000 claims description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims description 2
- 238000009472 formulation Methods 0.000 claims description 2
- 239000011780 sodium chloride Substances 0.000 claims description 2
- 239000002904 solvent Substances 0.000 claims description 2
- 239000004902 Softening Agent Substances 0.000 claims 1
- 238000012360 testing method Methods 0.000 description 16
- 239000000243 solution Substances 0.000 description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- 239000012530 fluid Substances 0.000 description 9
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 8
- 235000013601 eggs Nutrition 0.000 description 8
- 239000000523 sample Substances 0.000 description 7
- 238000005406 washing Methods 0.000 description 7
- 230000003013 cytotoxicity Effects 0.000 description 6
- 231100000135 cytotoxicity Toxicity 0.000 description 6
- 239000011521 glass Substances 0.000 description 6
- 241000283973 Oryctolagus cuniculus Species 0.000 description 5
- 244000100945 Piper peltatum Species 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 235000019441 ethanol Nutrition 0.000 description 5
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 4
- 229960000458 allantoin Drugs 0.000 description 4
- 238000010790 dilution Methods 0.000 description 4
- 239000012895 dilution Substances 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 241001251094 Formica Species 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000001476 alcoholic effect Effects 0.000 description 3
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000006260 foam Substances 0.000 description 3
- 239000002953 phosphate buffered saline Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000004448 titration Methods 0.000 description 3
- 241000991587 Enterovirus C Species 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 230000000855 fungicidal effect Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000002941 microtiter virus yield reduction assay Methods 0.000 description 2
- 230000000644 propagated effect Effects 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- BUAJNGPDPGKBGV-UHFFFAOYSA-N 1-(1-phenylcyclohexyl)piperidin-1-ium;chloride Chemical compound [Cl-].C1CCCC[NH+]1C1(C=2C=CC=CC=2)CCCCC1 BUAJNGPDPGKBGV-UHFFFAOYSA-N 0.000 description 1
- 241001103808 Albifimbria verrucaria Species 0.000 description 1
- 241000228245 Aspergillus niger Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 241001466953 Echovirus Species 0.000 description 1
- 241000709714 Echovirus E11 Species 0.000 description 1
- 241000709643 Echovirus E9 Species 0.000 description 1
- 241000712003 Human respirovirus 3 Species 0.000 description 1
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 1
- 241000282560 Macaca mulatta Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241001149951 Mucor mucedo Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 235000014676 Phragmites communis Nutrition 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 241001045770 Trichophyton mentagrophytes Species 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 210000003837 chick embryo Anatomy 0.000 description 1
- 210000000795 conjunctiva Anatomy 0.000 description 1
- 230000000120 cytopathologic effect Effects 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 150000001991 dicarboxylic acids Chemical class 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 239000012894 fetal calf serum Substances 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 230000035931 haemagglutination Effects 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 230000003699 hair surface Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000001524 infective effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 230000003641 microbiacidal effect Effects 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- -1 polyethylene Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000000954 titration curve Methods 0.000 description 1
- 239000003860 topical agent Substances 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
- A01N37/02—Saturated carboxylic acids or thio analogues thereof; Derivatives thereof
- A01N37/04—Saturated carboxylic acids or thio analogues thereof; Derivatives thereof polybasic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32061—Methods of inactivation or attenuation
- C12N2770/32063—Methods of inactivation or attenuation by chemical treatment
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Virology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Agronomy & Crop Science (AREA)
- Environmental Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Dentistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Communicable Diseases (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US93360278A | 1978-08-14 | 1978-08-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO792633L true NO792633L (no) | 1980-02-15 |
Family
ID=25464222
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO792633A NO792633L (no) | 1978-08-14 | 1979-08-13 | Fremgangsmaate og sammensetning for noeytralisering eller oedeleggelse av virus |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP0008121B1 (es) |
| JP (1) | JPS5531078A (es) |
| AR (1) | AR220769A1 (es) |
| AT (1) | AT368356B (es) |
| AU (1) | AU526595B2 (es) |
| CA (1) | CA1138335A (es) |
| DE (1) | DE2964902D1 (es) |
| DK (1) | DK338879A (es) |
| ES (1) | ES483358A1 (es) |
| FI (1) | FI792495A (es) |
| IE (1) | IE48397B1 (es) |
| IL (1) | IL58009A (es) |
| NO (1) | NO792633L (es) |
| NZ (1) | NZ191277A (es) |
| PT (1) | PT70063A (es) |
| ZA (1) | ZA794204B (es) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0049354A3 (en) * | 1980-09-08 | 1983-02-23 | Sterling Drug Inc. | Composition for therapeutic virucidal use, and articles and packages containing said composition |
| US4828912A (en) * | 1981-07-20 | 1989-05-09 | Kimberly-Clark Corporation | Virucidal product having virucidal and/or germicidal properties |
| DK315482A (da) * | 1981-07-20 | 1983-01-21 | Kimberly Clark Co | Fremgangsmaade til hindring af spredning af aandedraetsvira og middel til anvendelse ved fremgangsmaaden |
| US4738847A (en) * | 1985-01-14 | 1988-04-19 | Kimberly-Clark Corporation | Multi-ply virucidal product |
| AT382310B (de) * | 1985-09-30 | 1987-02-10 | Horst Felsch | Verfahren zur entkalkung, desinfektion und reinigung von mundduschen usw. |
| US6238682B1 (en) | 1993-12-13 | 2001-05-29 | The Procter & Gamble Company | Anhydrous skin lotions having antimicrobial components for application to tissue paper products which mitigate the potential for skin irritation |
| WO2001028339A2 (en) * | 1999-10-19 | 2001-04-26 | The Procter & Gamble Company | Antimicrobial compositions comprising a biologically active organic acid |
| US20050232868A1 (en) * | 1999-10-19 | 2005-10-20 | The Procter & Gamble Company | Methods of entrapping, inactivating, and removing viral infections by the administration of respiratory tract compositions |
| AU1096101A (en) * | 1999-10-19 | 2001-04-30 | Procter & Gamble Company, The | Antimicrobial compositions comprising a dicarboxylic acid and a metal salt |
| CN1852708B (zh) * | 2003-09-19 | 2010-09-22 | 大塚制药株式会社 | 人β防御素分泌促进剂 |
| US8741954B2 (en) | 2007-02-21 | 2014-06-03 | Viratox, L.L.C. | Synergistic enhancement of calcium propionate |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2227861B1 (es) * | 1973-05-04 | 1976-07-02 | Anvar |
-
1979
- 1979-08-08 IL IL58009A patent/IL58009A/xx unknown
- 1979-08-09 DE DE7979102884T patent/DE2964902D1/de not_active Expired
- 1979-08-09 EP EP79102884A patent/EP0008121B1/en not_active Expired
- 1979-08-10 AU AU49798/79A patent/AU526595B2/en not_active Ceased
- 1979-08-10 FI FI792495A patent/FI792495A/fi not_active Application Discontinuation
- 1979-08-10 NZ NZ191277A patent/NZ191277A/en unknown
- 1979-08-13 ZA ZA00794204A patent/ZA794204B/xx unknown
- 1979-08-13 DK DK338879A patent/DK338879A/da not_active Application Discontinuation
- 1979-08-13 IE IE1554/79A patent/IE48397B1/en unknown
- 1979-08-13 NO NO792633A patent/NO792633L/no unknown
- 1979-08-13 ES ES483358A patent/ES483358A1/es not_active Expired
- 1979-08-14 AR AR277714A patent/AR220769A1/es active
- 1979-08-14 PT PT70063A patent/PT70063A/pt unknown
- 1979-08-14 CA CA000333730A patent/CA1138335A/en not_active Expired
- 1979-08-14 AT AT0553279A patent/AT368356B/de not_active IP Right Cessation
- 1979-08-14 JP JP10348479A patent/JPS5531078A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AR220769A1 (es) | 1980-11-28 |
| PT70063A (en) | 1979-09-01 |
| ES483358A1 (es) | 1980-04-16 |
| ZA794204B (en) | 1980-08-27 |
| JPS5531078A (en) | 1980-03-05 |
| EP0008121A1 (en) | 1980-02-20 |
| CA1138335A (en) | 1982-12-28 |
| AT368356B (de) | 1982-10-11 |
| AU4979879A (en) | 1980-02-21 |
| FI792495A (fi) | 1980-02-15 |
| IL58009A (en) | 1982-11-30 |
| AU526595B2 (en) | 1983-01-20 |
| DK338879A (da) | 1980-02-15 |
| ATA553279A (de) | 1982-02-15 |
| EP0008121B1 (en) | 1983-02-23 |
| IL58009A0 (en) | 1979-12-30 |
| IE791554L (en) | 1980-02-14 |
| IE48397B1 (en) | 1985-01-09 |
| DE2964902D1 (en) | 1983-03-31 |
| NZ191277A (en) | 1984-07-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR870002047B1 (ko) | 비루스 박멸용 조성물 및 제품 | |
| US4828912A (en) | Virucidal product having virucidal and/or germicidal properties | |
| US4897304A (en) | Virucidal composition, the method of use and the product therefor | |
| US4767788A (en) | Glutaric acid virucidal processes and compositions | |
| De Benedictis et al. | Inactivation of avian influenza viruses by chemical agents and physical conditions: a review | |
| US7268163B2 (en) | Method for treating an inflammation or lesion caused by a virus | |
| NO792633L (no) | Fremgangsmaate og sammensetning for noeytralisering eller oedeleggelse av virus | |
| US6458346B1 (en) | Broad spectrum microbicidal and spermicidal compositions, devices, and methods | |
| EP0190797A2 (en) | Method for killing viruses and composition therefor | |
| CA2439413C (en) | Virucidal compositions | |
| Hendley et al. | Evaluation of virucidal compounds for inactivation of rhinovirus on hands | |
| US4200655A (en) | Benzyl alcohol virucidal process | |
| Eggers | Experiments on antiviral activity of hand disinfectants. Some theoretical and practical considerations | |
| CA2114470A1 (en) | Glutaraldehyde composition | |
| JP2567401B2 (ja) | 殺ウイルス用シート | |
| RU2359704C2 (ru) | Антисептическое и дезинфицирующее средство | |
| CN113855782B (zh) | 天麻多肽在制备抗新冠病毒的外用防护产品中的用途 | |
| Townsend et al. | Susceptibility of an avian pneumovirus isolated from Minnesota turkeys to physical and chemical agents | |
| CN113521261B (zh) | 一种抗冠状病毒和细菌双重纳米免洗消毒凝胶及其制备方法和应用 | |
| Mihai et al. | Survival of H5N1 influenza virus in water and its inactivation by chemical methods | |
| CN114377104A (zh) | 一种精油组合物、制备方法及应用 | |
| US5674829A (en) | Stable aqueous glutaraldehyde solutions containing sodium acetate and a nonionic detergent | |
| JP2004352642A (ja) | ウイルス感染症予防剤 | |
| Ansari et al. | The need and methods for assessing the activity of topical agents against viruses | |
| Grossgebauer | Assessment of virucidal ability of chemical disinfectants |